Discover the detailed record of transactions filed by Kapadia Sandip, Chief Financial Officer. Officer active across 1 companies, notably Harmony Biosciences Holdings, Inc.. Aggregated, 2 reports have been published. Total volume traded: €235k. The latest transaction was disclosed on 26 January 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Sandip Kapadia is the Chief Financial Officer of Harmony Biosciences Holdings, Inc. He is responsible for the company's financial management, including financial planning, risk management, and financial reporting. His role is essential in ensuring the financial health of the organization and supporting its strategic growth. With extensive expertise in the financial field, he contributes to informed decision-making within the company.